Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith A Morgan

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancerMeredith A Morgan, Leslie A Parsels, Laura E Kollar, et al.
Journal of Carcinogenesis & Mutagenesis|June 20, 2014
Glycogen Synthase Kinase 3β in Pancreatic Cancer and its Implications in Chemotherapy and Radiation TherapyQiang Zhang, Mahaveer S Bhojani, Edgar Ben-Josef, et al.
Nucleic Acids Research|February 6, 2019
The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage responseQiang Zhang, Ahmed S A Mady, Yuanyuan Ma, et al.
The Journal of Biological Chemistry|December 1, 2010
RBX1 (RING box protein 1) E3 ubiquitin ligase is required for genomic integrity by modulating DNA replication licensing proteinsLijun Jia, Jeremy S Bickel, Jiaxue Wu, et al.
Neoplasia (New York, N.Y.)|October 21, 2016
Fbxw7 Deletion Accelerates Kras<sup>G12D</sup>-Driven Pancreatic Tumorigenesis via Yap AccumulationQiang Zhang, Yaqing Zhang, Joshua D Parsels, et al.
Cancer Research|November 11, 2011
Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitorDongping Wei, Hua Li, Jie Yu, et al.
Cell Cycle (Georgetown, Tex.)|October 28, 2015
MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-strand break repair pathwaysAdriana Estrada-Bernal, Moumita Chatterjee, S Jaharul Haque, et al.
The Journal of Surgical Research|January 15, 2014
Checkpoint kinase 1 protein expression indicates sensitization to therapy by checkpoint kinase 1 inhibition in non-small cell lung cancerSvetlana Grabauskiene, Edward J Bergeron, Guoan Chen, et al.
Cell Cycle (Georgetown, Tex.)|December 3, 2011
Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1Sean Vance, Erqi Liu, Lili Zhao, et al.
Cell Cycle (Georgetown, Tex.)|February 19, 2016
Dissociation of gemcitabine chemosensitization by CHK1 inhibition from cell cycle checkpoint abrogation and aberrant mitotic entryLeslie A Parsels, Daria M Tanska, Joshua D Parsels, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancerMeredith A Morgan, Leslie A Parsels, Laura E Kollar, et al.
Journal of Carcinogenesis & Mutagenesis|June 20, 2014
Glycogen Synthase Kinase 3β in Pancreatic Cancer and its Implications in Chemotherapy and Radiation TherapyQiang Zhang, Mahaveer S Bhojani, Edgar Ben-Josef, et al.
Nucleic Acids Research|February 6, 2019
The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage responseQiang Zhang, Ahmed S A Mady, Yuanyuan Ma, et al.
The Journal of Biological Chemistry|December 1, 2010
RBX1 (RING box protein 1) E3 ubiquitin ligase is required for genomic integrity by modulating DNA replication licensing proteinsLijun Jia, Jeremy S Bickel, Jiaxue Wu, et al.
Neoplasia (New York, N.Y.)|October 21, 2016
Fbxw7 Deletion Accelerates Kras<sup>G12D</sup>-Driven Pancreatic Tumorigenesis via Yap AccumulationQiang Zhang, Yaqing Zhang, Joshua D Parsels, et al.
Cancer Research|November 11, 2011
Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitorDongping Wei, Hua Li, Jie Yu, et al.
Cell Cycle (Georgetown, Tex.)|October 28, 2015
MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-strand break repair pathwaysAdriana Estrada-Bernal, Moumita Chatterjee, S Jaharul Haque, et al.
The Journal of Surgical Research|January 15, 2014
Checkpoint kinase 1 protein expression indicates sensitization to therapy by checkpoint kinase 1 inhibition in non-small cell lung cancerSvetlana Grabauskiene, Edward J Bergeron, Guoan Chen, et al.
Cell Cycle (Georgetown, Tex.)|December 3, 2011
Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1Sean Vance, Erqi Liu, Lili Zhao, et al.
Cell Cycle (Georgetown, Tex.)|February 19, 2016
Dissociation of gemcitabine chemosensitization by CHK1 inhibition from cell cycle checkpoint abrogation and aberrant mitotic entryLeslie A Parsels, Daria M Tanska, Joshua D Parsels, et al.
Pageof 8